There are several biomarkers with probable utility in the context of diabetic kidney disease (DKD), including fibroblast growth factors 21 and 23 (FGF21, FGF23) and pigment epithelium-derived factor (PEDF), which are associated with inflammatory pathways and fibrosis [10]. The gene discussed is FGF21; the disease is diabetic kidney disease.